ALDH7A1 and cardiac hypertrophy: A loss of this early compensatory mechanism during progression/duration of cardiac hypertrophy due to NP and β-AR desensitization and/or phosphodiesterases (PDE) reorganization is very likely and can also explain the observed loss of positive inotropic effects of NPs in chronic stages of cardiac disease (as seen in our patient cohort) (8).